Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin G Vincent

Showing results (11-20 of 109) with videos related to

Pageof 11
Sort By:
EMBO Molecular Medicine|January 9, 2026
Pathobiology and clinical significance of malignant pleural effusionsAllison T Woods, Abner A Murray, Benjamin G Vincent, et al.
JCO Precision Oncology|January 7, 2022
Pursuing Better Biomarkers for Immunotherapy Response in Cancer Through a Crowdsourced Data ChallengeBenjamin G Vincent, Joseph D Szustakowski, Parul Doshi, et al.
Plos One|December 20, 2012
Autoreactive effector/memory CD4+ and CD8+ T cells infiltrating grafted and endogenous islets in diabetic NOD mice exhibit similar T cell receptor usageRamiro Diz, Alaina Garland, Benjamin G Vincent, et al.
Nature Reviews. Cancer|July 7, 2019
Alternative tumour-specific antigensChristof C Smith, Sara R Selitsky, Shengjie Chai, et al.
Translational Oncology|August 31, 2020
Tumor neoantigen heterogeneity impacts bystander immune inhibition of pancreatic cancer growthManisit Das, Xuefei Zhou, Yun Liu, et al.
Journal for Immunotherapy of Cancer|March 7, 2023
Evaluation of tumor antigen-specific antibody responses in patients with metastatic triple negative breast cancer treated with cyclophosphamide and pembrolizumabEric D Routh, Mark G Woodcock, Wolfgang Beckabir, et al.
Cancer Immunology Research|August 9, 2018
CD30-Redirected Chimeric Antigen Receptor T Cells Target CD30<sup>+</sup> and CD30<sup>-</sup> Embryonal Carcinoma via Antigen-Dependent and Fas/FasL InteractionsLee K Hong, Yuhui Chen, Christof C Smith, et al.
Journal of Diabetes Science and Technology|July 10, 2012
The use of peptide-major-histocompatibility-complex multimers in type 1 diabetes mellitusGreg S Gojanovich, Sabrina L Murray, Adam S Buntzman, et al.
Journal of the National Cancer Institute|June 24, 2016
Genomic Analysis of Immune Cell Infiltrates Across 11 Tumor TypesMichael D Iglesia, Joel S Parker, Katherine A Hoadley, et al.
Blood|May 18, 2018
Bim regulates the survival and suppressive capability of CD8<sup>+</sup> FOXP3<sup>+</sup> regulatory T cells during murine GVHDKimberle Agle, Benjamin G Vincent, Clint Piper, et al.
Pageof 11

Showing results (11-20 of 109) with videos related to

Sort By:
Pageof 11
EMBO Molecular Medicine|January 9, 2026
Pathobiology and clinical significance of malignant pleural effusionsAllison T Woods, Abner A Murray, Benjamin G Vincent, et al.
JCO Precision Oncology|January 7, 2022
Pursuing Better Biomarkers for Immunotherapy Response in Cancer Through a Crowdsourced Data ChallengeBenjamin G Vincent, Joseph D Szustakowski, Parul Doshi, et al.
Plos One|December 20, 2012
Autoreactive effector/memory CD4+ and CD8+ T cells infiltrating grafted and endogenous islets in diabetic NOD mice exhibit similar T cell receptor usageRamiro Diz, Alaina Garland, Benjamin G Vincent, et al.
Nature Reviews. Cancer|July 7, 2019
Alternative tumour-specific antigensChristof C Smith, Sara R Selitsky, Shengjie Chai, et al.
Translational Oncology|August 31, 2020
Tumor neoantigen heterogeneity impacts bystander immune inhibition of pancreatic cancer growthManisit Das, Xuefei Zhou, Yun Liu, et al.
Journal for Immunotherapy of Cancer|March 7, 2023
Evaluation of tumor antigen-specific antibody responses in patients with metastatic triple negative breast cancer treated with cyclophosphamide and pembrolizumabEric D Routh, Mark G Woodcock, Wolfgang Beckabir, et al.
Cancer Immunology Research|August 9, 2018
CD30-Redirected Chimeric Antigen Receptor T Cells Target CD30<sup>+</sup> and CD30<sup>-</sup> Embryonal Carcinoma via Antigen-Dependent and Fas/FasL InteractionsLee K Hong, Yuhui Chen, Christof C Smith, et al.
Journal of Diabetes Science and Technology|July 10, 2012
The use of peptide-major-histocompatibility-complex multimers in type 1 diabetes mellitusGreg S Gojanovich, Sabrina L Murray, Adam S Buntzman, et al.
Journal of the National Cancer Institute|June 24, 2016
Genomic Analysis of Immune Cell Infiltrates Across 11 Tumor TypesMichael D Iglesia, Joel S Parker, Katherine A Hoadley, et al.
Blood|May 18, 2018
Bim regulates the survival and suppressive capability of CD8<sup>+</sup> FOXP3<sup>+</sup> regulatory T cells during murine GVHDKimberle Agle, Benjamin G Vincent, Clint Piper, et al.
Pageof 11